Skip to main content
Erschienen in: Tobacco Induced Diseases 1/2014

Open Access 01.06.2014 | Meeting abstract

Maternal tobacco use during pregnancy and risk of congenital heart defects in offspring: a systematic review

verfasst von: Aspasia Tzani, Konstantinos P Economopoulos

Erschienen in: Tobacco Induced Diseases | Sonderheft 1/2014

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Background

Numerous human studies have investigated potential teratogenic effects of maternal smoking during pregnancy, with conflicting findings [1, 2]. One of the most common birth malformations is congenital heart defect (CHD) with a prevalence of around 1% of live births [3, 4]. More specifically, several studies indicate that maternal tobacco use is related with increased risk of CHD, whereas other studies do not find any association [5, 6]. The aim of this study is to systematically review the literature regarding the correlation between maternal smoking during pregnancy and the prevalence of CHDs in offspring.

Material and methods

A thorough up-to-date search of the English literature through PubMed identified studies of maternal smoking during pregnancy and CHD in infants. The selected Mesh terms included ”maternal”, “tobacco”, “smoking”, ”cigarette”, “pregnancy”, “cardiovascular”, “abnormalities” ”congenital abnormalities”, “congenital heart defect”, ”offspring”. The main parameters that were extracted from the eligible studies were maternal characteristics (age, weight, race, socioeconomic and health status), smoking habits (cigarettes per day, fetal exposure period) and CHD subtypes.

Results

The systematic search identified 874 articles, of which 37 met the inclusion criteria. Most studies have shown a strong correlation (OR: 2.06; 95% CI: 1.20–3.54) between mothers who reported medium and heavy smoking (≥1 pack per day) during the first semester of pregnancy and infants with septal heart defects than women who did not smoke during this time period. Maternal age, weight and socioeconomic status are independent confounding factors for neonatal heart defects. Women who smoked ≥25 cigarettes per day had increased risk to have infants with right-sided obstructive defects compared with nonsmoking mothers. Infants with CHD were more likely to be premature and have lower birth weight than healthy infants.

Conclusions

Maternal cigarette smoking during pregnancy is associated with congenital heart defects, especially with septal and right-side obstructive defects [7]. Additionally, future studies should take place in order to understand all underlying mechanisms and set the starting point of population-based prevention strategies so as to encourage more women to quit smoking before or early in pregnancy resulting in decreased infant mortality and morbidity.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​4.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Kallen K: Maternal smoking and congenital heart defects. Eur J Epidemiol. 1999, 15: 731-737. 10.1023/A:1007671631188.CrossRefPubMed Kallen K: Maternal smoking and congenital heart defects. Eur J Epidemiol. 1999, 15: 731-737. 10.1023/A:1007671631188.CrossRefPubMed
2.
Zurück zum Zitat Karatza AA, Giannakopoulos I, Dassios TG, Belavgenis G, Mantagos SP, Varvarigou AA: Periconceptional tobacco smoking and isolated congenital heart defects in the neonatal period. Int J Cardiol. 2011, 148: 295-299. 10.1016/j.ijcard.2009.11.008.CrossRefPubMed Karatza AA, Giannakopoulos I, Dassios TG, Belavgenis G, Mantagos SP, Varvarigou AA: Periconceptional tobacco smoking and isolated congenital heart defects in the neonatal period. Int J Cardiol. 2011, 148: 295-299. 10.1016/j.ijcard.2009.11.008.CrossRefPubMed
3.
Zurück zum Zitat Yerushalmy J: Congenital heart disease and maternal smoking habits. Nature. 1973, 242: 262-263. 10.1038/242262a0.CrossRefPubMed Yerushalmy J: Congenital heart disease and maternal smoking habits. Nature. 1973, 242: 262-263. 10.1038/242262a0.CrossRefPubMed
4.
Zurück zum Zitat Hackshaw A, Rodeck C, Boniface S: Maternal smoking in pregnancy and birth defects: a systematic review based on 173,687 malformed cases and 11.7 million controls. Hum Reprod Update. 2011, 17: 589-604. 10.1093/humupd/dmr022.PubMedCentralCrossRefPubMed Hackshaw A, Rodeck C, Boniface S: Maternal smoking in pregnancy and birth defects: a systematic review based on 173,687 malformed cases and 11.7 million controls. Hum Reprod Update. 2011, 17: 589-604. 10.1093/humupd/dmr022.PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Perspectives in pediatric cardiology. Epidemiology of congenital heart disease. The Baltimore-Washington Infant Study 1981–1989. Edited by: Ferencz C, Rubin JD, Loffredo CA, Magee CA. New York: Futura Pub, Mount Kisco, 4: 1993-last page. Perspectives in pediatric cardiology. Epidemiology of congenital heart disease. The Baltimore-Washington Infant Study 1981–1989. Edited by: Ferencz C, Rubin JD, Loffredo CA, Magee CA. New York: Futura Pub, Mount Kisco, 4: 1993-last page.
6.
Zurück zum Zitat Kuciene R, Dulskiene V: Maternal socioeconomic and lifestyle factors during pregnancy and the risk of congenital heart defects. Medicina Kaunas. 2009, 45: 904-909.PubMed Kuciene R, Dulskiene V: Maternal socioeconomic and lifestyle factors during pregnancy and the risk of congenital heart defects. Medicina Kaunas. 2009, 45: 904-909.PubMed
7.
Zurück zum Zitat Malik S, Cleves MA, Honein MA, Romitti PA, Botto LD, Yang S, Hobbs CA: National Birth Defects Prevention Study: Maternal smoking and congenital heart defects. Pediatrics. 2008, 121: e810-e816. 10.1542/peds.2007-1519.CrossRefPubMed Malik S, Cleves MA, Honein MA, Romitti PA, Botto LD, Yang S, Hobbs CA: National Birth Defects Prevention Study: Maternal smoking and congenital heart defects. Pediatrics. 2008, 121: e810-e816. 10.1542/peds.2007-1519.CrossRefPubMed
Metadaten
Titel
Maternal tobacco use during pregnancy and risk of congenital heart defects in offspring: a systematic review
verfasst von
Aspasia Tzani
Konstantinos P Economopoulos
Publikationsdatum
01.06.2014
Verlag
BioMed Central
Erschienen in
Tobacco Induced Diseases / Ausgabe Sonderheft 1/2014
Elektronische ISSN: 1617-9625
DOI
https://doi.org/10.1186/1617-9625-12-S1-A20

Weitere Artikel der Sonderheft 1/2014

Tobacco Induced Diseases 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.